Published in J Pediatr Surg on March 01, 2003
Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol (2009) 1.80
Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection. Surg Endosc (2008) 1.53
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors. Oncologist (2011) 0.96
Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials. Curr Oncol Rep (2008) 0.88
A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One (2013) 0.83
Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD/LtSz-scid IL2Rγnull mice. PLoS One (2011) 0.82
Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature (2010) 3.58
Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science (2009) 2.51
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma. Proc Natl Acad Sci U S A (2002) 2.45
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol (2008) 2.06
Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer (2011) 1.89
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc Natl Acad Sci U S A (2003) 1.82
A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res (2008) 1.80
Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor. J Pediatr Surg (2003) 1.59
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol (2010) 1.45
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. Drug Resist Updat (2004) 1.34
Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis. Mol Cancer Res (2004) 1.30
Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability. Cancer Res (2008) 1.29
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Mol Cancer Res (2008) 1.25
The use of endoscopic ultrasound in the diagnosis of solid pseudopapillary tumors of the pancreas in children. J Pediatr Surg (2002) 1.21
Comparative genomics of Klebsiella pneumoniae strains with different antibiotic resistance profiles. Antimicrob Agents Chemother (2011) 1.20
Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother (2002) 1.17
A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PLoS One (2012) 1.15
Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade. Int J Oncol (2009) 1.15
VEGF blocking therapy in the treatment of cancer. Expert Opin Biol Ther (2003) 1.07
Thoracoscopic lobectomy in infants less than 10 kg with prenatally diagnosed cystic lung disease. J Laparoendosc Adv Surg Tech A (2011) 1.07
Preoperative angiography with embolization and radiofrequency ablation as novel adjuncts to safe surgical resection of a large, vascular sacrococcygeal teratoma. Pediatr Surg Int (2006) 1.07
Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. J Control Release (2011) 1.06
Ultrasonography/MRI versus CT for diagnosing appendicitis. Pediatrics (2014) 1.05
Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. Ultrasound Med Biol (2012) 1.05
Notch: a key regulator of tumor angiogenesis and metastasis. Histol Histopathol (2012) 1.05
Vascular characterization of clear cell sarcoma of the kidney in a child: a case report and review. J Pediatr Surg (2009) 1.04
The effect of triton concentration on the activity of undecaprenyl pyrophosphate synthase inhibitors. J Biomol Screen (2003) 1.03
Limb ischemia after common femoral artery cannulation for venoarterial extracorporeal membrane oxygenation: an unresolved problem. J Pediatr Surg (2010) 1.00
Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma. Int J Oncol (2009) 0.99
Completely isolated alimentary tract duplication in a neonate. Pediatr Surg Int (2008) 0.98
Percutaneous distal perfusion of the lower extremity after femoral cannulation for venoarterial extracorporeal membrane oxygenation in a small child. J Pediatr Surg (2009) 0.98
Isolated primary testicular B lymphoblastic lymphoma: an unusual presentation. J Pediatr Hematol Oncol (2013) 0.97
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors. Oncologist (2011) 0.96
Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases. Bioorg Med Chem Lett (2013) 0.95
Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors. Mol Cancer Res (2005) 0.94
TNP-470 promotes initial vascular sprouting in xenograft tumors. Mol Cancer Ther (2004) 0.94
Laparoscopic excision of choledochal cysts with total intracorporeal reconstruction. J Laparoendosc Adv Surg Tech A (2010) 0.92
Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature. Int J Oncol (2004) 0.92
Congenital cutaneous hemangioma causing cardiac failure: a case report and review of the literature. Pediatr Dermatol (2012) 0.91
Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison. Pediatr Radiol (2008) 0.91
The use of recombinant tissue-type plasminogen activator in a newborn with an intracardiac thrombus developed during extracorporeal membrane oxygenation. J Pediatr Surg (2011) 0.90
Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. J Pediatr Surg (2013) 0.89
Biomolecular markers and involution of hemangiomas. J Pediatr Surg (2004) 0.89
PDE-constrained multispectral imaging of tissue chromophores with the equation of radiative transfer. Biomed Opt Express (2010) 0.89
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report. Clin Cancer Res (2012) 0.89
Opposing roles of RAGE and Myd88 signaling in extensive liver resection. FASEB J (2011) 0.89
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res (2006) 0.88
Duodenal atresia associated with proximal jejunal perforations: a case report and review of the literature. J Pediatr Surg (2003) 0.88
Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases. Bioorg Med Chem Lett (2011) 0.87
p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease. J Pediatr Surg (2002) 0.87
Role of salivary vascular endothelial growth factor (VEGF) in palatal mucosal wound healing. Wound Repair Regen (2013) 0.86
Factors influencing cellulosome activity in consolidated bioprocessing of cellulosic ethanol. Bioresour Technol (2010) 0.86
Distinct response of experimental neuroblastoma to combination antiangiogenic strategies. J Pediatr Surg (2002) 0.86